Entopsis Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 10
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $1.04M
Latest Deal Amount
  • Investors
  • 4

Entopsis General Information

Description

Developer of a medical device intended to utilize material science, chemistry and AI in creative ways to diagnose diseases. The company provides a universal platform, to diagnose numerous diseases through urine, that outperforms liquid biopsies and consists of a series of time and cost-saving technologies for research and clinical testing, thereby offering the bio-medical industry cost-effective and impactful diagnostic solutions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Primary Office
  • The Foundry
  • 7600 Northwest 69th Avenue
  • Medley, FL 33166
  • United States
+1 (888) 000-0000

Entopsis Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Entopsis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC (Series A) 01-Mar-2021 $1.04M 00.000 Completed Generating Revenue
6. Secondary Transaction - Private 01-Jan-2019 00.000 Completed Generating Revenue
5. Seed Round 10-Jan-2017 00000 00.000 Completed Generating Revenue
4. Seed Round 18-Mar-2015 00000 00000 Completed Generating Revenue
3. Product Crowdfunding 14-Sep-2014 0000 Completed Generating Revenue
2. Grant 20-Feb-2014 $1K Completed Generating Revenue
1. Grant 01-May-2012 $160K Completed Generating Revenue
To view Entopsis’s complete valuation and funding history, request access »

Entopsis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a medical device intended to utilize material science, chemistry and AI in creative ways to diagnose diseas
Diagnostic Equipment
Medley, FL
10 As of 2021
00.000
00000000000 00.000

0000000

t enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo cons
0000000000 000000000
Cambridge, United Kingdom
00 As of 0000
00000
0000 0000-00-00
000000&0 00000

00000

enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo conse
0000000000000
Menlo Park, CA
000 As of 0000
000
00 0000-00-00
000000&0 000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Entopsis Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inivata Formerly VC-backed Cambridge, United Kingdom 00 00000 000000&0 00000
00000 Formerly VC-backed Menlo Park, CA 000 000 000000&0 000
000000 0000000 000 Formerly VC-backed Cambridge, MA 000 00000 000000&0 00000
00000000 000000 Formerly VC-backed Redwood City, CA 000 00000 000000 - 000 00000
000000 00000000 Corporation Salt Lake City, UT 0000 00000 000000 - 000 00000
You’re viewing 5 of 5 competitors. Get the full list »

Entopsis Patents

Entopsis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200347380-A1 Separation device, and method of use, to remove pcr inhibitors from whole blood and serum samples Pending 06-Dec-2017 00000000000
CA-2923228-A1 Detectable array that can bind and detect multiple analytes and use thereof in diagnostic methods Pending 24-Sep-2013 000000000
AU-2014327042-A1 Detectable arrays, systems for diagnosis, and methods of making and using the same Abandoned 24-Sep-2013 000000000
JP-6587621-B2 Detectable array, diagnostic system, and method of making and using the same Active 24-Sep-2013 000000000
EP-3049560-A1 Detectable arrays, systems for diagnosis, and methods of making and using the same Granted 24-Sep-2013 C40B40/04
To view Entopsis’s complete patent history, request access »

Entopsis Executive Team (4)

Name Title Board Seat Contact Info
Obdulio Piloto Ph.D Co-Founder, Chief Executive Officer & Chairman
Chun Yi Huang Ph.D Chief Financial Officer & Board Member
Ian Cheong Ph.D Co-Founder, Chief Technology Officer & Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

Entopsis Board Members (3)

Name Representing Role Since
Chun Yi Huang Ph.D Entopsis Chief Financial Officer & Board Member 000 0000
Ian Cheong Ph.D Self Co-Founder, Chief Technology Officer & Board Member 000 0000
Obdulio Piloto Ph.D Entopsis Co-Founder, Chief Executive Officer & Chairman 000 0000
To view Entopsis’s complete board members history, request access »

Entopsis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Entopsis Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Conversant Bio Corporation Minority 000 0000 000000 0
G3 Capital Partners Venture Capital Minority 000 0000 000000 0
The Awesome Foundation Corporation 000 0000 000000 0
Breakout Labs Not-For-Profit Venture Capital 000 0000 000000 0
To view Entopsis’s complete investors history, request access »